Novo Nordisk ' s Once-weekly Basal Insulin Icodec Recommended for Marketing Approval in Europe Novo Nordisk ' s Once-weekly Basal Insulin Icodec Recommended for Marketing Approval in Europe

Danish drugmaker Novo Nordisk on Thursday said its once-weekly basal insulin icodec for treatment of diabetes in adults had received a recommendation for marketing...Reuters Health Information
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Source Type: news